AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. TNYA
  4. [SCHEDULE 13G/A] Tenaya Therapeutics, Inc. SEC Filing

[SCHEDULE 13G/A] Tenaya Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock TNYA logo
Tenaya Therapeutics, Inc.

NASDAQ:TNYA

TNYA Rankings

#6665 Ranked by Market Cap
N/A Ranked by Dividends

TNYA Latest News

Aug 8, 2025
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
Aug 6, 2025
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Jul 30, 2025
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed
May 15, 2025
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 13, 2025
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting

TNYA Latest SEC Filings

Aug 6, 2025
[10-Q] Tenaya Therapeutics, Inc. Quarterly Earnings Report
Aug 6, 2025
[8-K] Tenaya Therapeutics, Inc. Reports Material Event
Jul 31, 2025
[SCHEDULE 13G/A] Tenaya Therapeutics, Inc. SEC Filing

TNYA Stock Data

113.12M
161.04M
0.72%
59.67%
6.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SOUTH SAN FRANCISCO